Matches in SemOpenAlex for { <https://semopenalex.org/work/W2732920609> ?p ?o ?g. }
- W2732920609 endingPage "e353" @default.
- W2732920609 startingPage "e353" @default.
- W2732920609 abstract "Abstract Platinum chemotherapeutics are widely used to treat solid malignant tumors, including gastric cancer (GC). Drug resistance to platinum compounds may result in cancer relapse and decreased survival. The identification and development of novel agents to reactivate apoptosis pathways in platinum-resistant cancer cells is therefore necessary. Here we report that cisplatin-resistant human GC cells (BGC823/DDP and SGC7901/DDP) but not their parental cells (BGC823 and SGC7901) exhibit high sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a result of overexpression of death receptor 4 (DR4). Furthermore, we found that JWA, a molecule that promotes cisplatin-induced apoptosis in GC cells, suppressed TRAIL-induced apoptosis via negative regulation of DR4. Mechanistically, JWA promoted the ubiquitination of DR4 at K273 via upregulation of the ubiquitin ligase membrane-associated RING-CH-8 (MARCH8). In human GC tissues, JWA and DR4 protein levels were negatively correlated. Thus TRAIL may serve as an auxiliary treatment for cisplatin-resistant GC, and JWA may be a potential predictive marker of TRAIL sensitivity and may improve personalized therapeutics for treating human GC." @default.
- W2732920609 created "2017-07-14" @default.
- W2732920609 creator A5006619685 @default.
- W2732920609 creator A5008991235 @default.
- W2732920609 creator A5011034501 @default.
- W2732920609 creator A5011739925 @default.
- W2732920609 creator A5020080602 @default.
- W2732920609 creator A5022390001 @default.
- W2732920609 creator A5025071283 @default.
- W2732920609 creator A5037176711 @default.
- W2732920609 creator A5049218504 @default.
- W2732920609 creator A5054910338 @default.
- W2732920609 creator A5064023466 @default.
- W2732920609 creator A5068251286 @default.
- W2732920609 creator A5090684454 @default.
- W2732920609 date "2017-07-03" @default.
- W2732920609 modified "2023-10-14" @default.
- W2732920609 title "JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells" @default.
- W2732920609 cites W1616121322 @default.
- W2732920609 cites W1764242106 @default.
- W2732920609 cites W1970292153 @default.
- W2732920609 cites W1982560487 @default.
- W2732920609 cites W1983240885 @default.
- W2732920609 cites W1986637059 @default.
- W2732920609 cites W1990362215 @default.
- W2732920609 cites W1991886957 @default.
- W2732920609 cites W1999938241 @default.
- W2732920609 cites W2000377372 @default.
- W2732920609 cites W2005969350 @default.
- W2732920609 cites W2007718868 @default.
- W2732920609 cites W2008715871 @default.
- W2732920609 cites W2016286678 @default.
- W2732920609 cites W2025128734 @default.
- W2732920609 cites W2025965589 @default.
- W2732920609 cites W2031951376 @default.
- W2732920609 cites W2035588673 @default.
- W2732920609 cites W2038738703 @default.
- W2732920609 cites W2080761304 @default.
- W2732920609 cites W2090925992 @default.
- W2732920609 cites W2092524729 @default.
- W2732920609 cites W2093326276 @default.
- W2732920609 cites W2100378872 @default.
- W2732920609 cites W2110771191 @default.
- W2732920609 cites W2111034566 @default.
- W2732920609 cites W2129062251 @default.
- W2732920609 cites W2141037581 @default.
- W2732920609 cites W2143639277 @default.
- W2732920609 cites W2153226510 @default.
- W2732920609 cites W2153849263 @default.
- W2732920609 cites W2155816561 @default.
- W2732920609 cites W2156848272 @default.
- W2732920609 cites W2157963288 @default.
- W2732920609 cites W2158186953 @default.
- W2732920609 cites W2159515687 @default.
- W2732920609 cites W2164689082 @default.
- W2732920609 cites W2168083201 @default.
- W2732920609 cites W2171066507 @default.
- W2732920609 cites W2272315791 @default.
- W2732920609 cites W2290145688 @default.
- W2732920609 cites W2291355594 @default.
- W2732920609 cites W2308504656 @default.
- W2732920609 cites W2462979737 @default.
- W2732920609 cites W2525277364 @default.
- W2732920609 cites W2917837889 @default.
- W2732920609 doi "https://doi.org/10.1038/oncsis.2017.57" @default.
- W2732920609 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5541709" @default.
- W2732920609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28671676" @default.
- W2732920609 hasPublicationYear "2017" @default.
- W2732920609 type Work @default.
- W2732920609 sameAs 2732920609 @default.
- W2732920609 citedByCount "22" @default.
- W2732920609 countsByYear W27329206092017 @default.
- W2732920609 countsByYear W27329206092018 @default.
- W2732920609 countsByYear W27329206092019 @default.
- W2732920609 countsByYear W27329206092020 @default.
- W2732920609 countsByYear W27329206092021 @default.
- W2732920609 countsByYear W27329206092022 @default.
- W2732920609 countsByYear W27329206092023 @default.
- W2732920609 crossrefType "journal-article" @default.
- W2732920609 hasAuthorship W2732920609A5006619685 @default.
- W2732920609 hasAuthorship W2732920609A5008991235 @default.
- W2732920609 hasAuthorship W2732920609A5011034501 @default.
- W2732920609 hasAuthorship W2732920609A5011739925 @default.
- W2732920609 hasAuthorship W2732920609A5020080602 @default.
- W2732920609 hasAuthorship W2732920609A5022390001 @default.
- W2732920609 hasAuthorship W2732920609A5025071283 @default.
- W2732920609 hasAuthorship W2732920609A5037176711 @default.
- W2732920609 hasAuthorship W2732920609A5049218504 @default.
- W2732920609 hasAuthorship W2732920609A5054910338 @default.
- W2732920609 hasAuthorship W2732920609A5064023466 @default.
- W2732920609 hasAuthorship W2732920609A5068251286 @default.
- W2732920609 hasAuthorship W2732920609A5090684454 @default.
- W2732920609 hasBestOaLocation W27329206091 @default.
- W2732920609 hasConcept C104317684 @default.
- W2732920609 hasConcept C121608353 @default.
- W2732920609 hasConcept C127561419 @default.
- W2732920609 hasConcept C134459356 @default.
- W2732920609 hasConcept C17991360 @default.